Adenovirus-mediated CDglyTK fusion gene system driven by KDR promoter selectively kills colorectal cancer cells

Abstract

Abstract: Objective To observe the selective killing effect of adenovirus (Ad)-mediated double suicide gene driven by kinase domain-containing receptor(KDR) promoter on human colorectal cancer LoVo cells and human umbilical vein endothelial ECV304 cells.Methods The plasmid pAdEasy-KDR-CDglyTK was transfected into 293 packaging cells for amplification of the infectious Ad and used to infect the KDR-producing cells (ECV304 and LoVo) and the KDR-nonproducing cells (LS174T) respectively. The three cells were treated with the prodrugs 5-flurocytosine (5-FC) and ganciclovir (GCV) at different concentrations after infection. The killing effects of the fusion gene system on the cells were evaluated. The distribution of cell cycle was detected by flow cytometry.Results The infection rates of the recombinant Ad were similar among the 3 cells, gradually increasing with the increment of multiplicity of infection (MOI) and reaching 100% with the MOI of 200. The LoVo cells and ECV304 cells infected with Ad-KDR-CDglyTK were highly sensitive to both of the prodrugs (P>0.1), whereas the infected LS174T cells failed to exhibit similar sensitivity (P<0.001). The killing effect of CD/TK fusion gene on the target cells was much stronger than that of either suicide gene (P<0.001). The cell cycle of LoVo cells was arrested at G1 phase. Conclusion The CD/TK fusion gene system driven by KDR promoter can selectively kill KDR-expressing human colorectal cancer LoVo cells and endothelial cells.

CLC Number:

R730.59

LIN Rong-kai¹, HUANG Zong-hai¹, SU Guo-qiang¹, KE Zhi-yong², CHEN Jian-xiong¹, ZHOU Jin-jie¹. Adenovirus-mediated CDglyTK fusion gene system driven by KDR promoter selectively kills colorectal cancer cells[J]. Journal of Southern Medical University, 2005, 25(05): 524-527.

References

[1] 张振亚.大肠癌流行病学研究现状及展望[J].肿瘤防治研究(Cancer Res Prey Treat),2000,27(2):154-6.
[2] 陈建发,黄宗海,俞金龙,等.含血管内皮生长因子启动子驱动自杀基因重组腺病毒的制备及其体外杀伤作用观察[J].第一军医大学学报,2004,24(6):623-7.Chen JF, Huang ZH, Yu JL, et al. Construction of recombinant adenoviruses containing cytosine deaminase gene driven by the vascular endothelial growth factor promoter using an AdEsier-1system [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2004, 24(6): 623-7.
[3] Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells [J]. Microsc Res Tech, 2003, 60(1):70-5.
[4] 熊兵,易传勋,陈华德,等.转染血管内皮生长因子基因对大鼠任意皮瓣成活的影响[J].第一军医大学学报,2004,24(7):794-7Xiong B, Yi CX, Chen HD, et al. Vascular endothelial growth factor gene transfection and survival of the skin flap in rats[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2004, 24(7): 794-7.
[5] Ellis LM, Takahashi Y, Liu W. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications [J].Oncologist, 2000, 5(Suppl 1): 11-5.
[6] Harada Y, Ogata Y, Shirouzu K. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer[J]. Int J Clin Oncol, 2001, 6(5): 221-8.
[7] Beierle EA, Dai W, Langham MR Jr, et al. Expression of VEGF receptors in cocultured neuroblastoma cells [J]. J Surg Res, 2004,119(1): 56-65.
[8] Qi L, Robinson WA, Brady BM, et al. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors [J]. Anticancer Res, 2003, 23(5A): 3917-22.
[9] Lillo R, Ramirez M, Alvarez A, et al. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients[J]. Cancer Res, 2002, 62(17): 5013-8.
[10] VeldwijkMR, FruehaufS, SchiedlmeierB, et al. Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells [J]. Cancer Gene Ther,2000, 7(4): 597-604.
[11] He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses[J]. Proc Natl Acad Sci USA, 1998,95(5): 2509-14.
[12] Zeng M, Smith SK, Siegel F, et al. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination [J]. Biotechniques, 2001, 31 (2): 260-2.
[13] Rogulski KR, Kim JH, Kim SH, et al. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity[J]. Hum Gene Ther, 1997, 8(1): 73-85.